Latest / American Thought Leaders
A New Approach to Alzheimer’s? | Lou Reese
A typical vaccine stimulates a person’s immune system, yet only a portion of the immune response actually targets the disease it’s designed to protect against. However, a new technology may be changing that dynamic.
In this episode, I sit down with Lou Reese, an entrepreneur who has led or co-founded several biotech companies and has been working on synthetic peptide-based active immunotherapy medicines. He’s co-CEO of United Biomedical and co-founder of Vaxxinity, Cana Life, and Axxium.
He’s working on a product that could—if proven successful—transform our approach to treating and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.